Page last updated: 2024-08-23

dermatan sulfate and Blood Clot

dermatan sulfate has been researched along with Blood Clot in 110 studies

Research

Studies (110)

Timeframe	Studies, this research(%)	All Research%
pre-1990	17 (15.45)	18.7374
1990's	36 (32.73)	18.2507
2000's	40 (36.36)	29.6817
2010's	16 (14.55)	24.3611
2020's	1 (0.91)	2.80

Authors

Authors	Studies
Abe, K; Fujita, M; Hayashi, M; Hikichi, T; Imaizumi, H; Nakamura, J; Ohira, H; Sugaya, T; Takagi, T; Takahashi, A	1
Jennings, W; Mallios, A	1
Castelino, RL; Kairaitis, L; Maddula, M; Sud, K; Tarafdar, S	1
Harler, U; Joannidis, M; Lehner, GF; Pechlaner, C; Schöpf, M	1
Barbosa, GO; Carneiro, GD; Godoy, JA; Sielski, MS; Vicente, CP; Werneck, CC	1
Baumgarten, G; Kim, S; Koster, A; Riedel, R; Schewe, JC; Schmieder, A	1
Chong, BH; Isaacs, A	1
Chong, BH; Lip, GYH; Shantsila, E	1
Magnani, HN	2
Bidet, A; de Maistre, E; Desprez, D; Grunebaum, L; Huisse, MG; Lavenu-Bombled, C; Lecompte, T; Morange, P; Mouton, C; Pouplard, C; Presles, E; Racadot, E; Tardy Poncet, B; Tardy, B; Wolf, M	1
Bark, N; Blombäck, M; He, S; Johnsson, H; Wallén, NH	1
Kubo, Y; Miseki, T; Oku, T; Sakai, T; Sugata, H; Yamakawa, A	1
Ducrocq, X; Lacour, JC; Lavandier, K; Perrin, J; Richard, S	1
Block, DB; Godoy, JA; Tollefsen, DM; Vicente, CP; Werneck, CC	1
Ajzenberg, N; Aubier, B; Dilly, MP; Dufour, G; Lepage, L; Longrois, D; Montravers, P; Provenchere, S; Ricome, S	1
Borsig, L; Kozlowski, EO; Pavao, MS	1
Baglin, TP; Garcia, DA; Samama, MM; Weitz, JI	1
Hamada, K; Nakazawa, T; Nawata, Y; Nishino, N; Saitoh, S; Tajima, H; Tobayashi, K	1
Greinacher, A; Lubenow, N	2
Severin, T; Sutor, AH; Zieger, B	1
Myers, B; Strong, J; Westby, J	1
Kodityal, S; Manhas, AH; Rice, L; Udden, M	1
Opatrny, L; Warner, MN	1
Kreutzenbeck, HJ; Lindhoff-Last, E; Magnani, HN	1
Bartholomew, JR	1
de Mattos, DA; Mourão, PA; Nazareth, RA; Sarcinelli-Luz, BS; Stelling, MP; Tovar, AM	1
Cardin, AD; Hong, TT; Lucchesi, BR; Van Gorp, CL	1
Kossard, S; McGrath, M; Wells, J	1
Cardin, AD; Levy, JH; Szlam, F; Tanaka, KA; Vinten-Johansen, J	1
Bidlingmaier, C; Girisch, M; Kurnik, K; Magnani, HN	1
Cecere, R; De Varennes, B; Ergina, P; Lachapelle, K; Wan, C; Warner, M	1
Das, P; Hamdalla, H; Jozic, J; Moliterno, DJ; Mukherjee, D; Steinhubl, SR; Ziada, K	1
Tollefsen, DM	1
Babaev, A; Belway, D; Henley, B; Mesana, T; Rubens, FD	1
Haas, S; Höhnke, C	1
Greinacher, A; Selleng, K; Warkentin, TE	1
Merk, HF; Wurpts, G	1
Lindhoff-Last, E; Magnani, HN; Schindewolf, M	1
Bong, M; Di Cesare, PE; Patel, VP	1
Giri, TK; He, L; Tollefsen, DM; Vicente, CP	1
Bastien, O; Bauer, C; Ffrench, P; Hercule, C; Jegaden, O; Lehot, JJ; Vichova, Z	1
Rolfes, C; Steinfeldt, T	1
Harenberg, J; Kübler, W; Schwarz, F; Zimmermann, R	1
Borris, LC; Lassen, MR	1
Brister, SJ; Buchanan, MR	1
Aulmann, M; Fleischer, F; Martin, E; Nawroth, P; Remppis, A; Scheffler, E; Ziegler, R	1
Brister, SJ; Buchanan, MR; Gianese, F; Heigenhauser, GJ; Ofosu, FA	1
Ferrari, GP; Maggi, AP; Marchesini, D	1
Babbini, M; Barbanti, M; Bergonzini, G; Calanni, F; Marchi, E; Parma, B; Wassermann, A	1
Brister, SJ; Buchanan, MR; Ofosu, F	1
Cadroy, Y; Hanson, SR; Harker, LA	1
Kop, WJ; Meuleman, DG; van Amsterdam, RG; Vogel, GM	1
Görres, G; Marbet, GA; Ritz, R; Stöckli, TC; Walther, A	1
Augusseau-Richard, MP; Charbonnier, B; Dessenne, X; Pacouret, G; Pagot, O	1
Buczko, W; D'Adamo, MC; Donati, MB; Iacoviello, L; Pawlak, K; Polishchuck, R; Wollny, T	1
Leffringhausen, W; Scherlitzky, L; Wenzl, ME	1
Bartholomew, JR; Insler, SR; Kottke-Marchant, K; Kraenzler, EJ; Lytle, B; Starr, NJ	1
Hach-Wunderle, V; Kainer, K; Müller-Berghaus, G; Pötzsch, B; Salzmann, G	1
Buchwald, AB; Emig, U; Meyer, T	1
Boccardo, P; Boletta, A; Casiraghi, F; Gianese, F; Mecca, G; Melacini, D; Rota, S	1
Ofosu, FA	1
Bielawiec, M; Krupinski, K; Kyogashima, M; Takada, A; Takada, Y; Yoshida, K	1
Mazet, E; Piot, M; Tardy, B; Tardy-Poncet, B; Viallon, A	1
Breithardt, OA; Greinacher, A; Janssens, U	1
Black, MD; Edgell, D; Leaker, MT; Noel, D; Saxon, BR	1
Mörsdorf, S; Orthleb, R; Pindur, G; Pistorius, G; Schenk, J	1
Greinacher, A	1
Ariano, RE; Bhattacharya, SK; Brownell, LG; Moon, M	1
Warkentin, TE	1
Farnsworth, G; Haxby, EJ; Kanagasabay, R; Smith, EE; Unsworth-White, MJ	1
Caiola, E	1
Mourão, PA; Pacheco, RG; Vicente, CP; Zancan, P	1
Covi, P; Grubbauer, HM; Kroll, H; Kurnik, K; Muntean, W; Rettenbacher, A; Zenz, W; Zöhrer', B	1
Chong, BH; Keng, TB	1
Corno, A; Horisberger, J; Marty, B; Mueller, X; von Segesser, LK	1
Brister, SJ; Buchanan, MR; Maclean, GA	1
Bauersachs, R; Betz, C; Lindhoff-Last, E	1
Arthur, C; Cade, JF; Chesterman, CN; Chong, BH; Gallo, J; Gallus, AS; Lloyd, J; Magnani, H; Manoharan, A; Oldmeadow, M; Rickard, K; Seshadri, P	1
Alves-Sá, R; Araújo, FS; Mourão, PA; Pavão, MS; Peixoto, LL; Vicente, CP; Zancan, P	1
Bernat, C; Bontoux, L; Brunel, P; Cognet, F; Dubus-Bausière, V; Ménoret, N; Plassat, R; Richard, I; Ternisien, C	1
Boneu, B; Caranobe, C; Carrie, D; Gabaig, AM; Larroche, M	1
Califf, RM; Gockerman, JP; Greenberg, CS; McCann, RL; Metzler, DM; O'Connor, CM; Ortel, TL	1
Meuleman, DG	2
Danhof, M; de Boer, A; Magnani, HN; Stiekema, JC	1
Boisclair, M; Curtis, JR; Flynn, A; Ireland, H; Lane, DA; Ryan, KE; Shepperd, J	1
Ansell, J; Cola, C	1
Evans, S; Mansberg, R; Murray, B; Rowlings, PA; Rozenberg, MC	1
Casu, B; Fareed, J; Hoppensteadt, DA; Mantovani, M; Naggi, A; Pescador, R; Porta, R; Prino, G; Torri, G; Walenga, JM	1
Ahsan, A; Breddin, HK; Coyne, E; Fareed, J; Hoppensteadt, D; Walenga, JM	1
Gianese, F; Lucchelli, PE	1
Fareed, J; Hoppensteadt, D; Nurmohamed, MT; ten Cate, JW; Walenga, JM	1
Gray, E; Merton, RE; Thomas, DP	1
Messmore, HL	1
Andrew, M; Carter, CJ; Gent, M; Hirsh, J; Hull, RD; Jay, RM; Levine, MN; Magnani, HN; Powers, PJ; Turpie, AG	1
Büller, HR; Dabhoiwala, NF; Henny, CP; ten Cate, H; ten Cate, JW	1
Fareed, J; Hoppensteadt, D; Racanelli, A; Walenga, JM	1
Bourgondiën, FG; Hobbelen, PM; Meuleman, DG; Vogel, GM	1
Buchanan, M; Hirsh, J; Ofosu, F	1
Bara, L; Desnoyers, P; Samama, M	1
Cade, J; Chesterman, CN; Chong, BH; Gallus, AS; Gordon, S; Ismail, F	1
Boneu, B; Cadroy, Y; Caranobe, C; Choay, J; Dol, F; Lormeau, JC; Petitou, M; Sié, P	1
Boneu, B; Caranobe, C; Choay, J; Dol, F; Dupouy, D; Lormeau, JC; Petitou, M; Sié, P	1
Hobbelen, PM; Meuleman, DG; Vogel, GM	1
Büller, HR; Henny, CP; Peters, M; Prummel, MF; ten Cate, H; ten Cate, JW	1
Brandt, JT; Ezenagu, LC	1
Buchanan, MR; Fernandez, F; Hirsh, J; Ofosu, FA; Van Ryn, J	1
Carter, CJ; Hirsh, J; Ockelford, PA	1

Reviews

31 review(s) available for dermatan sulfate and Blood Clot

Article	Year
[Heparin-induced thrombocytopenia type II (HIT II) : A medical-economic view]. Medizinische Klinik, Intensivmedizin und Notfallmedizin, 2017, Volume: 112, Issue:4 Topics: Arginine; Chondroitin Sulfates; Costs and Cost Analysis; Dermatan Sulfate; Germany; Hemorrhage; Heparin; Heparitin Sulfate; Hospitalization; Humans; Pipecolic Acids; Risk Factors; Sulfonamides; Thrombocytopenia; Thrombosis; Treatment Outcome	2017
Heparin-induced thrombocytopenia: what clinicians need to know. Thrombosis and haemostasis, 2009, Volume: 101, Issue:2 Topics: Anticoagulants; Arginine; Autoantibodies; Chondroitin Sulfates; Dermatan Sulfate; Drug Monitoring; Fondaparinux; Heparin; Heparitin Sulfate; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Platelet Count; Platelet Factor 4; Polysaccharides; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Thrombosis; Warfarin	2009
Heparin-induced thrombocytopenia. A contemporary clinical approach to diagnosis and management. Chest, 2009, Volume: 135, Issue:6 Topics: Anticoagulants; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Female; Heparin; Heparitin Sulfate; Hirudins; Humans; Male; Monitoring, Physiologic; Peptide Fragments; Pipecolic Acids; Platelet Aggregation Inhibitors; Platelet Count; Prognosis; Randomized Controlled Trials as Topic; Recombinant Proteins; Risk Factors; Safety Management; Severity of Illness Index; Sulfonamides; Survival Rate; Thrombocytopenia; Thrombosis; Time Factors	2009
An analysis of clinical outcomes of 91 pregnancies in 83 women treated with danaparoid (Orgaran). Thrombosis research, 2010, Volume: 125, Issue:4 Topics: Abortion, Spontaneous; Chondroitin Sulfates; Dermatan Sulfate; Exanthema; Female; Hemorrhage; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Humans; Infant, Newborn; Infusions, Intravenous; Injections, Subcutaneous; Pregnancy; Research; Thrombosis; Treatment Outcome	2010
A review of 122 published outcomes of danaparoid anticoagulation for intermittent haemodialysis. Thrombosis research, 2010, Volume: 125, Issue:4 Topics: Chondroitin Sulfates; Dermatan Sulfate; Female; Hemorrhage; Heparin; Heparitin Sulfate; Humans; Platelet Count; Pregnancy; Recurrence; Renal Dialysis; Thrombosis; Treatment Outcome	2010
Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 2012, Volume: 141, Issue:2 Suppl Topics: Antithrombins; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Dose-Response Relationship, Drug; Evidence-Based Medicine; Fibrinolytic Agents; Fondaparinux; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Hirudins; Humans; Infusions, Intravenous; Peptide Fragments; Pipecolic Acids; Polysaccharides; Practice Guidelines as Topic; Recombinant Proteins; Societies, Medical; Sulfonamides; Thrombin; Thrombosis; United States	2012
Hirudin in heparin-induced thrombocytopenia. Seminars in thrombosis and hemostasis, 2002, Volume: 28, Issue:5 Topics: Anticoagulants; Antithrombins; Arginine; Blood Coagulation; Chondroitin Sulfates; Clinical Trials as Topic; Dermatan Sulfate; Drug Combinations; Fibrinolytic Agents; Heparin; Heparitin Sulfate; Hirudin Therapy; Hirudins; Humans; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Thrombosis; Time Factors	2002
Anticoagulation with recombinant hirudin and danaparoid sodium in pediatric patients. Seminars in thrombosis and hemostasis, 2002, Volume: 28, Issue:5 Topics: Adolescent; Anticoagulants; Child; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Female; Fibrinolytic Agents; Heparin; Heparitin Sulfate; Hirudin Therapy; Hirudins; Humans; Male; Thrombosis; Time Factors	2002
Drugs for the prevention and treatment of thrombosis in patients with heparin-induced thrombocytopenia. American journal of cardiovascular drugs : drugs, devices, and other interventions, 2001, Volume: 1, Issue:6 Topics: Animals; Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Heparin; Heparitin Sulfate; Hirudin Therapy; Humans; Thrombin; Thrombocytopenia; Thrombosis	2001
Treatment of 51 pregnancies with danaparoid because of heparin intolerance. Thrombosis and haemostasis, 2005, Volume: 93, Issue:1 Topics: Adult; Chondroitin Sulfates; Cross Reactions; Dermatan Sulfate; Drug Evaluation; Drug Hypersensitivity; Exanthema; Female; Hemorrhage; Heparin; Heparitin Sulfate; Humans; MEDLINE; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Retrospective Studies; Thrombocytopenia; Thrombosis	2005
Transition to an oral anticoagulant in patients with heparin-induced thrombocytopenia. Chest, 2005, Volume: 127, Issue:2 Suppl Topics: Administration, Oral; Anticoagulants; Arginine; Blood Coagulation; Blood Coagulation Factors; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Gangrene; Heparin; Heparitin Sulfate; Hirudins; Humans; Ischemia; Leg; Necrosis; Pipecolic Acids; Recombinant Proteins; Skin; Sulfonamides; Thrombocytopenia; Thrombosis; Warfarin	2005
Heparin-induced thrombocytopenia and cardiovascular diseases. American heart journal, 2006, Volume: 152, Issue:1 Topics: Anticoagulants; Arginine; Cardiac Surgical Procedures; Cardiovascular Diseases; Chondroitin Sulfates; Dermatan Sulfate; Diagnosis, Differential; Fondaparinux; Heparin; Heparitin Sulfate; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Platelet Aggregation Inhibitors; Platelet Factor 4; Polysaccharides; Recombinant Proteins; Sensitivity and Specificity; Sulfonamides; Thrombocytopenia; Thrombosis	2006
Heparin cofactor II modulates the response to vascular injury. Arteriosclerosis, thrombosis, and vascular biology, 2007, Volume: 27, Issue:3 Topics: Animals; Atherosclerosis; Coronary Restenosis; Dermatan Sulfate; Disease Models, Animal; Female; Heparin Cofactor II; Humans; Male; Mice; Mice, Knockout; Muscle, Smooth, Vascular; Pregnancy; Sensitivity and Specificity; Structure-Activity Relationship; Thrombin; Thrombosis; Tunica Intima	2007
Heparin-induced thrombocytopenia in intensive care patients. Critical care medicine, 2007, Volume: 35, Issue:4 Topics: Anticoagulants; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Extracorporeal Circulation; Heparin; Heparitin Sulfate; Hirudins; Humans; Intensive Care Units; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombin; Thrombocytopenia; Thrombosis	2007
Heparin-induced thrombocytopenia and thrombosis. American journal of orthopedics (Belle Mead, N.J.), 2007, Volume: 36, Issue:5 Topics: Anticoagulants; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Heparin; Heparitin Sulfate; Hirudins; Humans; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Thrombosis	2007
A comparative review of the adverse effect profiles of heparins and heparinoids. Drug safety, 1995, Volume: 12, Issue:1 Topics: Chondroitin Sulfates; Dermatan Sulfate; Fibrinolytic Agents; Hemorrhage; Heparin; Heparinoids; Heparitin Sulfate; Hip Prosthesis; Humans; Molecular Weight; Postoperative Complications; Thrombocytopenia; Thrombosis; Wound Infection	1995
Prevention and treatment of thrombosis: novel strategies arising from our understanding the healthy endothelium. Wiener klinische Wochenschrift, 1993, Volume: 105, Issue:11 Topics: Animals; Antithrombins; Dermatan Sulfate; Endothelium, Vascular; Epoprostenol; Hemostasis; Heparitin Sulfate; Humans; Linoleic Acids; Nitric Oxide; Platelet Aggregation; Thrombosis	1993
[Successful lysis of iliofemoral and inferior vena cava thrombi in heparin-induced type-II thrombocytopenia]. Deutsche medizinische Wochenschrift (1946), 1997, Aug-01, Volume: 122, Issue:31-32 Topics: Adult; Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Female; Femoral Vein; Heparin; Heparinoids; Heparitin Sulfate; Humans; Iliac Vein; Plasminogen Activators; Pulmonary Embolism; Recurrence; Thrombocytopenia; Thrombolytic Therapy; Thrombosis; Urokinase-Type Plasminogen Activator; Vena Cava Filters; Vena Cava, Inferior	1997
Pharmacological actions of sulodexide. Seminars in thrombosis and hemostasis, 1998, Volume: 24, Issue:2 Topics: Animals; Anticoagulants; Biological Availability; Blood Coagulation; Carotid Artery Thrombosis; Clinical Trials as Topic; Dermatan Sulfate; Drug Administration Routes; Drug Evaluation, Preclinical; Endothelium, Vascular; Fibrinolytic Agents; Glycosaminoglycans; Hemorrhage; Heparin; Humans; Molecular Weight; Multicenter Studies as Topic; Myocardial Infarction; Partial Thromboplastin Time; Rabbits; Rats; Thrombosis	1998
Treatment of heparin-induced thrombocytopenia. Thrombosis and haemostasis, 1999, Volume: 82, Issue:2 Topics: Adult; Ancrod; Antibodies; Anticoagulants; Antigen-Antibody Complex; Antithrombins; Child; Chondroitin Sulfates; Cross Reactions; Dermatan Sulfate; Drug Combinations; Extracorporeal Circulation; Female; Heparin; Heparitin Sulfate; Hirudin Therapy; Hirudins; Humans; Platelet Factor 4; Pregnancy; Pregnancy Complications, Hematologic; Thrombocytopenia; Thrombolytic Therapy; Thrombosis	1999
Heparin-induced thrombocytopenia: how to manage it, how to avoid it. Cleveland Clinic journal of medicine, 2000, Volume: 67, Issue:9 Topics: Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Epoprostenol; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Hirudin Therapy; Hirudins; Humans; Platelet Aggregation Inhibitors; Recombinant Proteins; Thrombocytopenia; Thrombosis	2000
Alternatives to unfractionated heparin for anticoagulation in cardiopulmonary bypass. Perfusion, 2001, Volume: 16, Issue:5 Topics: Abciximab; Ancrod; Antibodies, Monoclonal; Anticoagulants; Arginine; Cardiopulmonary Bypass; Chondroitin Sulfates; Cross Reactions; Dermatan Sulfate; Drug Combinations; Drug Hypersensitivity; Factor Xa Inhibitors; Hemodilution; Hemorrhage; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Hirudin Therapy; Humans; Immunoglobulin Fab Fragments; Perfusion; Pipecolic Acids; Platelet Aggregation Inhibitors; Protamines; Sulfonamides; Thrombocytopenia; Thrombophilia; Thrombosis; Tirofiban; Tyrosine	2001
[Heparin induced thrombocytopenia: case report with acute thrombotic complications and literature review]. Annales de readaptation et de medecine physique : revue scientifique de la Societe francaise de reeducation fonctionnelle de readaptation et de medecine physique, 2002, Volume: 45, Issue:5 Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Knee; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Female; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Humans; Thrombocytopenia; Thrombosis	2002
Orgaran (Org 10172): its pharmacological profile in experimental models. Haemostasis, 1992, Volume: 22, Issue:2 Topics: Animals; Carbohydrate Sequence; Chondroitin Sulfates; Dermatan Sulfate; Factor Xa Inhibitors; Fibrinolytic Agents; Glycosaminoglycans; Hemorrhage; Heparinoids; Heparitin Sulfate; Molecular Sequence Data; Platelet Aggregation; Rabbits; Rats; Thrombin; Thrombolytic Therapy; Thrombosis	1992
Pharmacokinetic considerations on Orgaran (Org 10172) therapy. Haemostasis, 1992, Volume: 22, Issue:2 Topics: Adult; Aged; Animals; Binding, Competitive; Biological Availability; Chondroitin Sulfates; Dermatan Sulfate; Drug Evaluation, Preclinical; Drug Interactions; Factor Xa Inhibitors; Female; Glycosaminoglycans; Half-Life; Heparin, Low-Molecular-Weight; Heparinoids; Heparitin Sulfate; Humans; Male; Metabolic Clearance Rate; Middle Aged; Prothrombin; Rats; Thrombosis	1992
Heparin-induced thrombocytopenia and arterial thrombosis: alternative therapies. American heart journal, 1990, Volume: 119, Issue:2 Pt 1 Topics: Aspirin; Cardiopulmonary Bypass; Chondroitin Sulfates; Dermatan Sulfate; Epoprostenol; Fibrinolytic Agents; Glycosaminoglycans; Heparin; Heparinoids; Heparitin Sulfate; Humans; Iloprost; Necrosis; Platelet Aggregation Inhibitors; Skin; Skin Diseases; Thrombocytopenia; Thrombosis	1990
A survey of the clinical experience with dermatan sulfate. Seminars in thrombosis and hemostasis, 1991, Volume: 17 Suppl 2 Topics: Animals; Blood Coagulation; Blood Coagulation Tests; Dermatan Sulfate; Drug Evaluation; Drug Evaluation, Preclinical; Fibrinolytic Agents; Heparin Cofactor II; Humans; Infusions, Intravenous; Injections, Intramuscular; Injections, Intravenous; Injections, Subcutaneous; Rabbits; Rats; Renal Dialysis; Swine; Thrombin; Thrombolytic Therapy; Thrombosis	1991
Pharmacological and clinical studies with Lomoparan, a low molecular weight glycosaminoglycan. Seminars in thrombosis and hemostasis, 1991, Volume: 17 Suppl 2 Topics: Animals; Anticoagulants; Blood Coagulation; Cerebrovascular Disorders; Chondroitin Sulfates; Dermatan Sulfate; Drug Evaluation, Preclinical; Fibrinolytic Agents; Glycosaminoglycans; Hemorrhage; Heparin; Heparitin Sulfate; Humans; Incidence; Mammals; Molecular Weight; Platelet Aggregation; Postoperative Complications; Rabbits; Renal Dialysis; Thrombocytopenia; Thrombophlebitis; Thrombosis	1991
Clinical use of heparin fractions, fragments, and heparinoids. Seminars in thrombosis and hemostasis, 1985, Volume: 11, Issue:2 Topics: Animals; Cardiopulmonary Bypass; Chondroitin Sulfates; Clinical Trials as Topic; Dermatan Sulfate; Factor X; Factor Xa; Fibrinolytic Agents; Glycosaminoglycans; Heparin; Heparinoids; Heparitin Sulfate; Humans; Kinetics; Molecular Weight; Postoperative Complications; Rats; Renal Dialysis; Thrombocytopenia; Thrombosis; Uremia	1985
Rationale behind the development of low molecular weight heparin derivatives. Seminars in thrombosis and hemostasis, 1985, Volume: 11, Issue:1 Topics: Animals; Antithrombin III; Blood Coagulation; Blood Platelets; Dermatan Sulfate; Dose-Response Relationship, Drug; Factor X; Factor Xa; Hemorrhage; Heparin; Humans; Molecular Weight; Pentosan Sulfuric Polyester; Platelet Aggregation; Prothrombin; Structure-Activity Relationship; Sulfates; Thrombosis	1985
[Dermatan sulfate and the prevention of experimental venous thrombosis]. Pathologie-biologie, 1989, Volume: 37, Issue:6 Topics: Animals; Antithrombin III; Antithrombins; Blood Coagulation; Blood Platelets; Chondroitin; Dermatan Sulfate; Glycoproteins; Heparin Cofactor II; Humans; Models, Biological; Rabbits; Rats; Thrombosis	1989

Trials

8 trial(s) available for dermatan sulfate and Blood Clot

Article	Year
Effects of antithrombin and heparin cofactor II levels on anticoagulation with Intimatan. Thrombosis and haemostasis, 2005, Volume: 94, Issue:4 Topics: Anticoagulants; Blood Coagulation; Dermatan Sulfate; Drug Therapy, Combination; Heparin; Heparin Cofactor II; Humans; Partial Thromboplastin Time; Prothrombin Time; Thrombin; Thrombosis	2005
[Danaparoid in pregnancy in cases of heparin intolerance - use in 59 cases]. Hamostaseologie, 2007, Volume: 27, Issue:2 Topics: Adult; Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Factor Xa Inhibitors; Female; Heparin; Heparitin Sulfate; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Thrombocytopenia; Thrombosis	2007
Individualized anticoagulation with dermatan sulphate for haemodialysis in chronic renal failure. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1997, Volume: 12, Issue:11 Topics: Aged; Anticoagulants; Cross-Over Studies; Dermatan Sulfate; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Partial Thromboplastin Time; Renal Dialysis; Thrombosis	1997
Prospective randomised open-label comparison of danaparoid with dextran 70 in the treatment of heparin-induced thrombocytopaenia with thrombosis: a clinical outcome study. Thrombosis and haemostasis, 2001, Volume: 86, Issue:5 Topics: Aged; Chondroitin Sulfates; Dermatan Sulfate; Dextrans; Drug Combinations; Drug Therapy, Combination; Female; Heparin; Heparitin Sulfate; Humans; Male; Middle Aged; Prospective Studies; Survival Rate; Therapeutic Equivalency; Thrombocytopenia; Thrombosis; Treatment Outcome; Warfarin	2001
Antithrombotic properties of dermatan sulphate (MF 701) in haemodialysis for chronic renal failure. Thrombosis and haemostasis, 1992, Nov-10, Volume: 68, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antithrombin III; Blood Coagulation; Dermatan Sulfate; Dose-Response Relationship, Drug; Female; Fibrinolytic Agents; Fibrinopeptide A; Heparin; Humans; Kidney Failure, Chronic; Male; Middle Aged; Peptide Hydrolases; Renal Dialysis; Thrombosis	1992
Clinical use of heparin fractions, fragments, and heparinoids. Seminars in thrombosis and hemostasis, 1985, Volume: 11, Issue:2 Topics: Animals; Cardiopulmonary Bypass; Chondroitin Sulfates; Clinical Trials as Topic; Dermatan Sulfate; Factor X; Factor Xa; Fibrinolytic Agents; Glycosaminoglycans; Heparin; Heparinoids; Heparitin Sulfate; Humans; Kinetics; Molecular Weight; Postoperative Complications; Rats; Renal Dialysis; Thrombocytopenia; Thrombosis; Uremia	1985
Double-blind randomised trial of Org 10172 low-molecular-weight heparinoid in prevention of deep-vein thrombosis in thrombotic stroke. Lancet (London, England), 1987, Mar-07, Volume: 1, Issue:8532 Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Cerebrovascular Disorders; Chondroitin Sulfates; Clinical Trials as Topic; Dermatan Sulfate; Female; Fibrinolytic Agents; Follow-Up Studies; Glycosaminoglycans; Heparin; Heparinoids; Heparitin Sulfate; Humans; Injections, Intravenous; Injections, Subcutaneous; Male; Middle Aged; Radiography; Random Allocation; Thrombosis; Time Factors	1987
Randomized double-blind, placebo controlled safety study of a low molecular weight heparinoid in patients undergoing transurethral resection of the prostate. Thrombosis and haemostasis, 1987, Feb-03, Volume: 57, Issue:1 Topics: Aged; Aged, 80 and over; Bleeding Time; Chondroitin Sulfates; Dermatan Sulfate; Double-Blind Method; Erythrocyte Transfusion; Glycosaminoglycans; Hematocrit; Heparinoids; Heparitin Sulfate; Humans; Male; Middle Aged; Molecular Weight; Placebos; Prostate; Random Allocation; Thrombosis; Urethra	1987

Other Studies

72 other study(ies) available for dermatan sulfate and Blood Clot

Article	Year
Sigmoid Colon Varices due to Massive Thrombosis of a Noncirrhotic Extrahepatic Portosystemic Shunt. Internal medicine (Tokyo, Japan), 2020, Nov-01, Volume: 59, Issue:21 Topics: Adult; Anticoagulants; Chondroitin Sulfates; Colon, Sigmoid; Dermatan Sulfate; Factor Xa Inhibitors; Heparitin Sulfate; Hepatic Encephalopathy; Humans; Male; Portal Vein; Portasystemic Shunt, Transjugular Intrahepatic; Pyridines; Thiazoles; Thrombosis; Treatment Outcome; Varicose Veins	2020
White Clot Syndrome. European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, 2018, Volume: 55, Issue:3 Topics: Aged; Anticoagulants; Chondroitin Sulfates; Computed Tomography Angiography; Dermatan Sulfate; Diagnosis, Differential; Female; Heparin; Heparitin Sulfate; Humans; Platelet Count; Syndrome; Thrombectomy; Thrombocytopenia; Thrombosis	2018
Danaparoid use for haemodialysis in a morbidly obese patient with heparin-induced thrombocytopenia - Need for a higher than recommended weight-based dosing. Thrombosis research, 2019, Volume: 180 Topics: Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Dose-Response Relationship, Drug; Female; Heparin; Heparitin Sulfate; Humans; Obesity, Morbid; Renal Dialysis; Thrombocytopenia; Thrombosis	2019
Repeated premature hemofilter clotting during regional citrate anticoagulation as indicator of heparin induced thrombocytopenia. Blood purification, 2014, Volume: 38, Issue:2 Topics: Acute Kidney Injury; Aged; Anticoagulants; Chondroitin Sulfates; Citrates; Dermatan Sulfate; Equipment Failure; Female; Heparin; Heparitin Sulfate; Humans; Immunoglobulin G; Platelet Factor 4; Renal Dialysis; Shock, Septic; Thrombocytopenia; Thrombosis	2014
Combined dermatan sulfate and endothelial progenitor cell treatment: action on the initial inflammatory response after arterial injury in C57BL/6 mice. Cytotherapy, 2015, Volume: 17, Issue:10 Topics: Animals; Anti-Inflammatory Agents; Bone Marrow Cells; Carotid Arteries; Carotid Artery Injuries; Cell Adhesion; Cell Adhesion Molecules; Cell Movement; Cells, Cultured; Chemokine CXCL12; Combined Modality Therapy; Dermatan Sulfate; Endothelial Progenitor Cells; Fibrinolytic Agents; Intercellular Adhesion Molecule-1; Male; Mice; Mice, Inbred C57BL; Nitric Oxide Synthase Type III; P-Selectin; Thrombosis; Vascular Remodeling	2015
Clinical characteristics and laboratory testing of patients with suspected HIT: a survey on current practice in 11 university hospitals in France. Thrombosis research, 2010, Volume: 125, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Chondroitin Sulfates; Clinical Laboratory Techniques; Data Collection; Dermatan Sulfate; Female; France; Heparin; Heparitin Sulfate; Hospitals, University; Humans; Male; Medical Records; Middle Aged; Practice Patterns, Physicians'; Thrombocytopenia; Thrombosis; Young Adult	2010
The direct thrombin inhibitors (argatroban, bivalirudin and lepirudin) and the indirect Xa-inhibitor (danaparoid) increase fibrin network porosity and thus facilitate fibrinolysis. Thrombosis and haemostasis, 2010, Volume: 103, Issue:5 Topics: Antithrombins; Arginine; Chondroitin Sulfates; Chromatography, Gel; Dermatan Sulfate; Factor VIII; Factor Xa Inhibitors; Fibrin; Fibrinolysis; Heparinoids; Heparitin Sulfate; Hirudins; Humans; In Vitro Techniques; Microscopy, Confocal; Peptide Fragments; Pipecolic Acids; Plasma; Porosity; Protein Multimerization; Recombinant Proteins; Sulfonamides; Thrombosis; Tissue Plasminogen Activator	2010
[A case of portal vein thrombosis complicating acute cholangitis treated successfully with danaparoid sodium]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2010, Volume: 107, Issue:11 Topics: Acute Disease; Aged, 80 and over; Anticoagulants; Cholangitis; Chondroitin Sulfates; Dermatan Sulfate; Female; Gallstones; Heparitin Sulfate; Humans; Portal Vein; Thrombosis	2010
Cerebral venous thrombosis due to essential thrombocythemia and worsened by heparin-induced thrombocytopenia and thrombosis. Platelets, 2011, Volume: 22, Issue:2 Topics: Anticoagulants; Cerebral Veins; Chondroitin Sulfates; Decompressive Craniectomy; Dermatan Sulfate; Female; Heparin; Heparitin Sulfate; Humans; Intracranial Hypertension; Middle Aged; Platelet Count; Radiography; Thrombocythemia, Essential; Thrombocytopenia; Thrombosis; Treatment Outcome; Venous Thrombosis	2011
Dermatan sulfate and bone marrow mononuclear cells used as a new therapeutic strategy after arterial injury in mice. Cytotherapy, 2011, Volume: 13, Issue:6 Topics: Animals; Anticoagulants; Bone Marrow Cells; Carotid Arteries; Dermatan Sulfate; Leukocyte Common Antigens; Mice; Mice, Inbred C57BL; Neointima; P-Selectin; Thrombosis	2011
Two cases of valvular thrombosis secondary to heparin-induced thrombocytopenia managed without surgery. Circulation, 2011, Mar-29, Volume: 123, Issue:12 Topics: Aged, 80 and over; Anticoagulants; Aortic Valve Stenosis; Chondroitin Sulfates; Dermatan Sulfate; Echocardiography, Transesophageal; Female; Fibrinolytic Agents; Heart Valve Prosthesis; Heparin; Heparitin Sulfate; Humans; Middle Aged; Thrombocytopenia; Thrombosis; Tomography, X-Ray Computed	2011
Ascidian dermatan sulfates attenuate metastasis, inflammation and thrombosis by inhibition of P-selectin. Journal of thrombosis and haemostasis : JTH, 2011, Volume: 9, Issue:9 Topics: Animals; Cell Line, Tumor; Colonic Neoplasms; Dermatan Sulfate; Humans; Inflammation; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Knockout; Neoplasm Metastasis; Neoplasms, Experimental; Neutrophils; P-Selectin; Thrombosis; Urochordata	2011
[Successful use of danaparoid in the treatment of portal vein thrombosis that developed in a warfarin-administered hepatitis C virus-related cirrhosis patient]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2012, Volume: 109, Issue:8 Topics: Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Chondroitin Sulfates; Dermatan Sulfate; Female; Heparitin Sulfate; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Portal Vein; Thrombosis; Warfarin	2012
Prophylactic use of danaparoid in high-risk pregnancy with heparin-induced thrombocytopaenia-positive skin reaction. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2003, Volume: 14, Issue:5 Topics: Adult; Anticoagulants; Cesarean Section; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Drug Eruptions; Emergencies; Female; Heparin; Heparitin Sulfate; Humans; Infant, Newborn; Injections, Subcutaneous; Platelet Count; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy, High-Risk; Pregnancy, Multiple; Puerperal Disorders; Pulmonary Embolism; Thrombocytopenia; Thrombosis; Warfarin	2003
Danaparoid for heparin-induced thrombocytopenia: an analysis of treatment failures. European journal of haematology, 2003, Volume: 71, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Chondroitin Sulfates; Cross Reactions; Dermatan Sulfate; Disseminated Intravascular Coagulation; Drug Combinations; Female; Heparin; Heparitin Sulfate; Humans; Male; Middle Aged; Platelet Count; Thrombocytopenia; Thrombosis; Treatment Failure	2003
Risk of thrombosis in patients with malignancy and heparin-induced thrombocytopenia. American journal of hematology, 2004, Volume: 76, Issue:3 Topics: Aged; Aged, 80 and over; Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Female; Heparin; Heparitin Sulfate; Humans; Male; Middle Aged; Neoplasms; Pulmonary Embolism; Retrospective Studies; Risk Factors; Thrombocytopenia; Thrombosis; Venous Thrombosis	2004
Dermatan sulfate is the predominant antithrombotic glycosaminoglycan in vessel walls: implications for a possible physiological function of heparin cofactor II. Biochimica et biophysica acta, 2005, Apr-15, Volume: 1740, Issue:1 Topics: Anticoagulants; Aorta, Thoracic; Dermatan Sulfate; Endothelium, Vascular; Fibrinolytic Agents; Heparin Cofactor II; Heparitin Sulfate; Humans; Saphenous Vein; Thrombosis	2005
Intimatan (dermatan 4,6-O-disulfate) prevents rethrombosis after successful thrombolysis in the canine model of deep vessel wall injury. Thrombosis research, 2006, Volume: 117, Issue:3 Topics: Animals; Anticoagulants; Arteries; Bleeding Time; Blood Coagulation; Blood Platelets; Dermatan Sulfate; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Female; Heparin Cofactor II; Male; Models, Chemical; Platelet Aggregation; Prothrombin Time; Recombinant Proteins; Thrombin; Thrombolytic Therapy; Thrombosis; Time Factors; Tissue Plasminogen Activator	2006
Abdominal wall ulceration and mucinosis secondary to recombinant human interferon-beta-1b. The Australasian journal of dermatology, 2005, Volume: 46, Issue:3 Topics: Abdominal Wall; Adjuvants, Immunologic; Chondroitin Sulfates; Dermatan Sulfate; Enoxaparin; Female; Fibrinolytic Agents; Heparitin Sulfate; Humans; Injections, Subcutaneous; Interferon beta-1b; Interferon-beta; Middle Aged; Mucinoses; Multiple Sclerosis; Thrombosis; Treatment Outcome; Ulcer	2005
Safety and efficacy of danaparoid (Orgaran) use in children. Acta haematologica, 2006, Volume: 115, Issue:3-4 Topics: Adolescent; Adult; Child; Child, Preschool; Chondroitin Sulfates; Dermatan Sulfate; Drug Evaluation; Fibrinolytic Agents; Hemorrhage; Heparin; Heparitin Sulfate; Humans; Infant; Infant, Newborn; Male; Purpura, Thrombocytopenic, Idiopathic; Risk Factors; Thrombosis	2006
Clinical presentation, temporal relationship, and outcome in thirty-three patients with type 2 heparin-induced thrombocytopenia after cardiotomy. The Annals of thoracic surgery, 2006, Volume: 82, Issue:1 Topics: Aged; Aged, 80 and over; Anticoagulants; Autoantibodies; Cardiac Surgical Procedures; Chondroitin Sulfates; Cohort Studies; Dermatan Sulfate; Diabetes Complications; Female; Gangrene; Heparin; Heparitin Sulfate; Hospital Mortality; Humans; Ischemia; Male; Middle Aged; Platelet Factor 4; Postoperative Complications; Postoperative Period; Retrospective Studies; Risk Factors; Thrombocytopenia; Thrombosis; Time Factors; Treatment Outcome	2006
Delayed thrombin generation is not associated with fibrinopeptide formation during prolonged cardiopulmonary bypass with hirudin anticoagulation. Perfusion, 2006, Volume: 21, Issue:5 Topics: Adult; Anticoagulants; Cardiopulmonary Bypass; Chondroitin Sulfates; Contraindications; Dermatan Sulfate; Endarterectomy; Fibrinolytic Agents; Fibrinopeptide A; Heparin; Heparitin Sulfate; Hirudins; Humans; Hypertension, Pulmonary; Hypothermia, Induced; Male; Peptide Fragments; Postoperative Complications; Prothrombin; Pulmonary Embolism; Purpura, Thrombocytopenic, Idiopathic; Recombinant Proteins; Thrombectomy; Thrombin; Thrombosis	2006
[Two surgical case reports showing atypical heparin-induced thrombocytopenia]. Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 2007, Volume: 78, Issue:2 Topics: Adult; Anticoagulants; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Drug Eruptions; Female; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Hirudins; Humans; Male; Pipecolic Acids; Platelet Count; Platelet Factor 4; Postoperative Complications; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Thrombosis; Time Factors	2007
[Delayed intracutaneous test reaction in heparin intolerance]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2007, Volume: 58, Issue:5 Topics: Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Drug Eruptions; Heparitin Sulfate; Humans; Hypersensitivity, Delayed; Injections, Subcutaneous; Intradermal Tests; Male; Thrombosis	2007
Vascular dermatan sulfate regulates the antithrombotic activity of heparin cofactor II. Blood, 2008, Apr-15, Volume: 111, Issue:8 Topics: Animals; Carotid Arteries; Chondroitin Lyases; Dermatan Sulfate; Female; Fibrinolytic Agents; Heparin Cofactor II; Heparitin Sulfate; Humans; Light; Male; Mice; Mice, Inbred C57BL; Mutant Proteins; Recombinant Proteins; Substrate Specificity; Swine; Thrombin; Thrombosis; Time Factors	2008
Extracorporeal membrane oxygenation with danaparoid sodium after massive pulmonary embolism. Anesthesia and analgesia, 2008, Volume: 106, Issue:4 Topics: Adult; Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Echocardiography, Transesophageal; Extracorporeal Membrane Oxygenation; Factor Xa; Heparitin Sulfate; Humans; Iliac Vein; Male; Portal Vein; Pulmonary Embolism; Thrombocytopenia; Thrombosis; Tomography, X-Ray Computed	2008
[Heparin induced thrombocytopenia and anticoagulation in renal replacemant therapy]. Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS, 2008, Volume: 43, Issue:4 Topics: Acute Kidney Injury; Anticoagulants; Arginine; Blood Coagulation Tests; Chondroitin Sulfates; Citrates; Critical Care; Dermatan Sulfate; Diagnostic Errors; Dose-Response Relationship, Drug; Epoprostenol; Fondaparinux; Hemofiltration; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Hirudins; Humans; Iloprost; Pipecolic Acids; Polysaccharides; Recombinant Proteins; Sodium Citrate; Sulfonamides; Thrombocytopenia; Thrombosis	2008
Treatment of heparin-induced thrombocytopenia with thrombosis by new heparinoid. Lancet (London, England), 1983, Apr-30, Volume: 1, Issue:8331 Topics: Chondroitin Sulfates; Dermatan Sulfate; Fibrinolytic Agents; Glycosaminoglycans; Heparin; Heparitin Sulfate; Humans; Male; Middle Aged; Pulmonary Embolism; Thrombocytopenia; Thrombosis	1983
Heparinless cardiopulmonary bypass revisited: a newer strategy to avoid heparin-related bleeding using dermatan sulfate. Journal of cardiothoracic and vascular anesthesia, 1995, Volume: 9, Issue:3 Topics: Animals; Anticoagulants; Antithrombin III; Blood Loss, Surgical; Cardiopulmonary Bypass; Dermatan Sulfate; Fibrin; Heart Diseases; Heparin; Heparin Cofactor II; Intracranial Embolism and Thrombosis; Sternum; Surface Properties; Swine; Thoracotomy; Thrombin; Thrombosis; Whole Blood Coagulation Time	1995
[Successful use of a heparinoid (danaparoid sodium) for heparin-induced thrombocytopenia type II in aortic valve reoperation]. Zeitschrift fur Kardiologie, 1995, Volume: 84, Issue:7 Topics: Adult; Aortic Valve Stenosis; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Heart Valve Prosthesis; Heparin; Heparitin Sulfate; Heroin Dependence; Humans; Male; Platelet Count; Postoperative Complications; Prosthesis Failure; Reoperation; Thrombocytopenia; Thrombosis	1995
Is heparin the ideal anticoagulant for cardiopulmonary bypass? Dermatan sulphate may be an alternate choice. Thrombosis and haemostasis, 1994, Volume: 71, Issue:4 Topics: Animals; Blood Coagulation Tests; Blood Loss, Surgical; Cardiopulmonary Bypass; Dermatan Sulfate; Drug Evaluation, Preclinical; Hemorrhage; Heparin; Intraoperative Complications; Swine; Thrombosis	1994
Preliminary chemical, biochemical, and pharmacological characterization of a low molecular weight dermatan sulphate. Carbohydrate research, 1994, Mar-04, Volume: 255 Topics: Animals; Anticoagulants; Biological Availability; Carbohydrate Sequence; Dermatan Sulfate; Molecular Sequence Data; Molecular Weight; Rabbits; Rats; Thrombosis	1994
Antithrombotic activity of Desmin 370. Comparison with a high molecular weight dermatan sulfate. Thrombosis research, 1993, Sep-01, Volume: 71, Issue:5 Topics: Animals; Biological Availability; Dermatan Sulfate; Drug Evaluation, Preclinical; Fibrinolytic Agents; Injections, Intramuscular; Injections, Intravenous; Injections, Subcutaneous; Male; Molecular Weight; Rats; Rats, Sprague-Dawley; Thrombosis; Vena Cava, Inferior	1993
Dermatan sulfate inhibition of fibrin-rich thrombus formation in nonhuman primates. Arteriosclerosis and thrombosis : a journal of vascular biology, 1993, Volume: 13, Issue:8 Topics: Animals; Blood Platelets; Dermatan Sulfate; Dose-Response Relationship, Drug; Fibrin; Hemostasis; Male; Papio; Thrombin; Thrombosis	1993
Pentasaccharide and Orgaran arrest, whereas heparin delays thrombus formation in a rat arteriovenous shunt. Thrombosis and haemostasis, 1993, Jan-11, Volume: 69, Issue:1 Topics: Animals; Arteriovenous Shunt, Surgical; Chondroitin Sulfates; Dermatan Sulfate; Factor Xa Inhibitors; Glycosaminoglycans; Heparin; Heparitin Sulfate; Male; Oligosaccharides; Platelet Adhesiveness; Platelet Count; Prothrombin; Rats; Rats, Wistar; Thrombin; Thrombosis; Time Factors	1993
[Heparin-induced thrombopenia and thrombosis]. Schweizerische medizinische Wochenschrift, 1996, Mar-23, Volume: 126, Issue:12 Topics: Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Fractures, Bone; Heparin; Heparinoids; Heparitin Sulfate; Humans; Male; Middle Aged; Pelvic Bones; Pulmonary Embolism; Thrombocytopenia; Thrombosis	1996
[Anticoagulant therapy in pulmonary embolism]. Archives des maladies du coeur et des vaisseaux, 1995, Volume: 88, Issue:11 Suppl Topics: Anticoagulants; Chondroitin Sulfates; Coumarins; Dermatan Sulfate; Drug Administration Schedule; Drug Combinations; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Hirudin Therapy; Humans; Injections, Intravenous; Partial Thromboplastin Time; Pulmonary Embolism; Thrombolytic Therapy; Thrombosis; Treatment Outcome	1995
Antithrombotic activity of dermatan sulphates, heparins and their combination in an animal model of arterial thrombosis. Thrombosis and haemostasis, 1996, Volume: 76, Issue:6 Topics: Animals; Anticoagulants; Dermatan Sulfate; Disease Models, Animal; Drug Therapy, Combination; Glycosaminoglycans; Heparin; Male; Rats; Thrombosis	1996
[Loss of extremities caused by heparin-induced thrombocytopenia]. Der Unfallchirurg, 1996, Volume: 99, Issue:8 Topics: Aged; Amputation, Surgical; Arm; Chondroitin Sulfates; Dermatan Sulfate; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Female; Fibrinolytic Agents; Heparin; Heparitin Sulfate; Humans; Middle Aged; Platelet Aggregation; Risk Factors; Thrombocytopenia; Thrombosis	1996
Thrombosis during the use of the heparinoid Organon 10172 in a patient with heparin-induced thrombocytopenia. Anesthesiology, 1997, Volume: 86, Issue:2 Topics: Aged; Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Heparin; Heparitin Sulfate; Humans; Male; Thrombocytopenia; Thrombosis	1997
Heparin-related thrombosis despite normal platelet counts in vascular surgery. American journal of surgery, 1997, Volume: 173, Issue:2 Topics: Adult; Aged; Anastomosis, Surgical; Arterial Occlusive Diseases; Autoantibodies; Blood Platelets; Blood Vessel Prosthesis; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Female; Graft Occlusion, Vascular; Heparin; Heparinoids; Heparitin Sulfate; Humans; Intraoperative Complications; Male; Middle Aged; Platelet Count; Reoperation; Thrombosis; Vascular Patency	1997
Dermatan sulfate enhances the lysis of laser-induced thrombus in vivo. Thrombosis research, 1998, Aug-15, Volume: 91, Issue:4 Topics: Animals; Anticoagulants; Dermatan Sulfate; Injections, Intraperitoneal; Lasers; Male; Rats; Rats, Wistar; Thrombosis	1998
Fatal danaparoid-sodium induced thrombocytopenia and arterial thromboses. Thrombosis and haemostasis, 1998, Volume: 80, Issue:3 Topics: Aged; Anticoagulants; Arteries; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Fatal Outcome; Heparinoids; Heparitin Sulfate; Humans; Male; Pulmonary Embolism; Thrombocytopenia; Thrombosis	1998
Successful thrombolysis of right atrial and ventricle thrombi encircling a temporary pacemaker lead in a patient with heparin-induced thrombocytopenia type II. Pacing and clinical electrophysiology : PACE, 1999, Volume: 22, Issue:4 Pt 1 Topics: Aged; Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Fibrinolytic Agents; Heart Atria; Heart Diseases; Heart Ventricles; Heparin; Heparinoids; Heparitin Sulfate; Hirudin Therapy; Hirudins; Humans; Pacemaker, Artificial; Thrombocytopenia; Thrombolytic Therapy; Thrombosis; Tissue Plasminogen Activator	1999
Pediatric heparin-induced thrombocytopenia: management with Danaparoid (orgaran). The Annals of thoracic surgery, 1999, Volume: 68, Issue:3 Topics: Anticoagulants; Cardiopulmonary Bypass; Child, Preschool; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Female; Heart Defects, Congenital; Hemorrhage; Heparin; Heparitin Sulfate; Humans; Thrombocytopenia; Thrombosis	1999
[Late onset of heparin-induced thrombocytopenia with recurrent arterial thromboses and amputation]. Deutsche medizinische Wochenschrift (1946), 1999, Oct-29, Volume: 124, Issue:43 Topics: Aged; Aged, 80 and over; Amputation, Surgical; Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Endarterectomy; Female; Heparin; Heparinoids; Heparitin Sulfate; Humans; Ischemia; Leg; Recurrence; Thrombocytopenia; Thromboembolism; Thrombosis	1999
Failure of danaparoid anticoagulation for cardiopulmonary bypass. The Journal of thoracic and cardiovascular surgery, 2000, Volume: 119, Issue:1 Topics: Aged; Angina, Unstable; Anticoagulants; Cardiopulmonary Bypass; Chondroitin Sulfates; Coronary Disease; Dermatan Sulfate; Drug Combinations; Heparin; Heparitin Sulfate; Humans; Male; Reoperation; Thrombocytopenia; Thrombosis; Treatment Failure	2000
Heparin-induced thrombocytopenia and its treatment. Journal of thrombosis and thrombolysis, 2000, Volume: 9 Suppl 1 Topics: Ancrod; Anticoagulants; Antithrombins; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Hirudin Therapy; Hirudins; Humans; Recombinant Proteins; Thrombocytopenia; Thrombosis; Warfarin	2000
Cardiopulmonary bypass and heparin-induced thrombocytopenia: pitfalls of anticoagulation with danaparoid. The Journal of thoracic and cardiovascular surgery, 2000, Volume: 120, Issue:2 Topics: Ancrod; Anticoagulants; Aprotinin; Cardiopulmonary Bypass; Chondroitin Sulfates; Coronary Disease; Dermatan Sulfate; Drug Combinations; Heparin; Heparitin Sulfate; Humans; Serine Proteinase Inhibitors; Thrombocytopenia; Thrombosis; Treatment Failure	2000
Different antithrombotic mechanisms among glycosaminoglycans revealed with a new fucosylated chondroitin sulfate from an echinoderm. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2000, Volume: 11, Issue:6 Topics: Animals; Anticoagulants; Carbohydrate Sequence; Chondroitin Sulfates; Dermatan Sulfate; Disease Models, Animal; Dose-Response Relationship, Drug; Echinodermata; Female; Fibrinolytic Agents; Fucose; Glycosaminoglycans; Heparin; Male; Molecular Sequence Data; Molecular Weight; Partial Thromboplastin Time; Rats; Sulfur Radioisotopes; Thrombosis	2000
Danaparoid sodium (Orgaran) in four children with heparin-induced thrombocytopenia type II. Acta paediatrica (Oslo, Norway : 1992), 2001, Volume: 90, Issue:7 Topics: Adolescent; Antibodies, Antiphospholipid; Anticoagulants; Child; Chondroitin Sulfates; Dermatan Sulfate; Female; Heparin; Heparitin Sulfate; Humans; Male; Thrombocytopenia; Thrombosis; Treatment Outcome	2001
Heparin-induced thrombocytopenia and thrombosis syndrome: in vivo cross-reactivity with danaparoid and successful treatment with r-Hirudin. British journal of haematology, 2001, Volume: 114, Issue:2 Topics: Aged; Antibodies; Anticoagulants; Chondroitin Sulfates; Cross Reactions; Dermatan Sulfate; Drug Combinations; Factor Xa; Heparin; Heparitin Sulfate; Hirudin Therapy; Humans; International Normalized Ratio; Male; Platelet Count; Syndrome; Thrombocytopenia; Thrombosis	2001
Selective and sustained inhibition of surface-bound thrombin activity by intimatan/heparin cofactor II and its relevance to assessing systemic anticoagulation in vivo, ex vivo and in vitro. Thrombosis and haemostasis, 2001, Volume: 86, Issue:3 Topics: Animals; Anticoagulants; Blood Coagulation Tests; Carotid Artery Injuries; Cell Membrane; Dermatan Sulfate; Drug Evaluation, Preclinical; Endothelium, Vascular; Female; Heparin Cofactor II; Humans; Male; Partial Thromboplastin Time; Prothrombin; Rabbits; Thrombin; Thrombosis	2001
Use of a low-molecular-weight heparinoid (danaparoid sodium) for continuous renal replacement therapy in intensive care patients. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2001, Volume: 7, Issue:4 Topics: Adult; Aged; Anticoagulants; Chondroitin Sulfates; Contraindications; Critical Care; Dermatan Sulfate; Drug Combinations; Drug Evaluation; Female; Hemorrhage; Heparin; Heparinoids; Heparitin Sulfate; Humans; Male; Middle Aged; Multiple Organ Failure; Renal Replacement Therapy; Retrospective Studies; Thrombosis; Treatment Outcome	2001
Unbalanced effects of dermatan sulfates with different sulfation patterns on coagulation, thrombosis and bleeding. Thrombosis and haemostasis, 2001, Volume: 86, Issue:5 Topics: Animals; Anticoagulants; Blood Coagulation; Cattle; Dermatan Sulfate; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Female; Hemorrhage; Heparin Cofactor II; Male; Protein Binding; Rats; Rats, Wistar; Species Specificity; Thrombin; Thrombosis; Urochordata	2001
Effects of heparin, dermatan sulfate and of their association on the inhibition of venous thrombosis growth in the rabbit. Thrombosis and haemostasis, 1992, Dec-07, Volume: 68, Issue:6 Topics: Animals; Dermatan Sulfate; Dose-Response Relationship, Drug; Drug Therapy, Combination; Heparin; Infusions, Intravenous; Injections, Intravenous; Jugular Veins; Male; Partial Thromboplastin Time; Rabbits; Thrombosis	1992
Parenteral anticoagulation with the heparinoid Lomoparan (Org 10172) in patients with heparin induced thrombocytopenia and thrombosis. Thrombosis and haemostasis, 1992, Mar-02, Volume: 67, Issue:3 Topics: Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Female; Glycosaminoglycans; Heparin; Heparinoids; Heparitin Sulfate; Humans; Infusions, Intravenous; Male; Middle Aged; Platelet Aggregation; Thrombocytopenia; Thrombosis	1992
The use of a low molecular weight heparinoid (Org 10172) for extracorporeal procedures in patients with heparin dependent thrombocytopenia and thrombosis. Australian and New Zealand journal of medicine, 1991, Volume: 21, Issue:1 Topics: Aged; Cardiopulmonary Bypass; Chondroitin Sulfates; Dermatan Sulfate; Female; Fibrinolytic Agents; Glycosaminoglycans; Heparin; Heparinoids; Heparitin Sulfate; Humans; Renal Dialysis; Thrombocytopenia; Thrombosis	1991
Pharmacologic profile of sulfamino-galactosaminoglycans. Seminars in thrombosis and hemostasis, 1991, Volume: 17 Suppl 1 Topics: Animals; Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Fat Emulsions, Intravenous; Fibrinolytic Agents; Humans; Lipase; Male; Phosphatidylcholines; Rats; Rats, Inbred Strains; Sheep; Structure-Activity Relationship; Thrombosis	1991
Molecular and functional heterogeneity in dermatan sulfate preparations. Seminars in thrombosis and hemostasis, 1991, Volume: 17 Suppl 2 Topics: Animals; Anticoagulants; Blood Coagulation; Chromatography, Gel; Dermatan Sulfate; Dogs; Fibrinolytic Agents; Glycosaminoglycans; Humans; Molecular Weight; Rabbits; Swine; Thrombosis	1991
Potentiation of the antithrombotic action of dermatan sulphate by small amounts of heparin. Thrombosis and haemostasis, 1990, Oct-22, Volume: 64, Issue:2 Topics: Animals; Blood Coagulation; Dermatan Sulfate; Drug Evaluation, Preclinical; Drug Synergism; Heparin; Rabbits; Thrombin; Thrombosis	1990
Synopsis of the anticoagulant and antithrombotic profile of the low molecular weight heparinoid Org 10172 in experimental models. Seminars in thrombosis and hemostasis, 1989, Volume: 15, Issue:4 Topics: Animals; Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Drug Evaluation, Preclinical; Fibrinolytic Agents; Glycosaminoglycans; Hemorrhage; Heparin; Heparin, Low-Molecular-Weight; Heparinoids; Heparitin Sulfate; Injections, Intravenous; Injections, Subcutaneous; Rabbits; Rats; Thrombosis	1989
Comparative antithrombotic and hemorrhagic effects of dermatan sulfate, heparan sulfate, and heparin. Seminars in thrombosis and hemostasis, 1989, Volume: 15, Issue:4 Topics: Animals; Blood Coagulation Tests; Chondroitin; Dermatan Sulfate; Fibrinolytic Agents; Glycosaminoglycans; Hemorrhage; Heparin; Heparitin Sulfate; Male; Rabbits; Thrombosis	1989
Comparison of two experimental thrombosis models in rats effects of four glycosaminoglycans. Thrombosis research, 1989, Jun-01, Volume: 54, Issue:5 Topics: Animals; Arteriovenous Shunt, Surgical; Aspirin; Blood Coagulation Factors; Blood Platelets; Chondroitin Sulfates; Coumarins; Dermatan Sulfate; Disease Models, Animal; Fibrin; Fibrinolytic Agents; Glycosaminoglycans; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Immune Sera; Ligation; Male; Oligosaccharides; Rats; Thrombosis; Venae Cavae; Vitamin K	1989
Heparin-induced thrombocytopenia: studies with a new low molecular weight heparinoid, Org 10172. Blood, 1989, May-01, Volume: 73, Issue:6 Topics: Antigen-Antibody Reactions; Blood Platelets; Chondroitin Sulfates; Cross Reactions; Dermatan Sulfate; Glycosaminoglycans; Heparin; Heparitin Sulfate; Humans; In Vitro Techniques; Molecular Weight; Platelet Aggregation Inhibitors; Thrombocytopenia; Thrombosis; Thromboxane B2	1989
Standard heparin enhances the antithrombotic activity of dermatan sulfate in the rabbit but CY 216 does not. Thrombosis and haemostasis, 1988, Apr-08, Volume: 59, Issue:2 Topics: Animals; Chondroitin; Dermatan Sulfate; Dose-Response Relationship, Drug; Drug Synergism; Factor Xa; Fibrinolytic Agents; Heparin; Heparin, Low-Molecular-Weight; Male; Prothrombin; Rabbits; Serine Proteinase Inhibitors; Thrombosis	1988
Effects of increased sulfation of dermatan sulfate on its in vitro and in vivo pharmacological properties. Thrombosis research, 1988, Oct-15, Volume: 52, Issue:2 Topics: Animals; Chondroitin; Dermatan Sulfate; Disease Models, Animal; Fibrinolytic Agents; Half-Life; Humans; Metabolic Clearance Rate; Partial Thromboplastin Time; Rabbits; Sulfuric Acids; Thrombosis	1988
Time courses of the antithrombotic effects, bleeding enhancing effects and interactions with factors Xa and thrombin after administration of low molecular weight heparinoid Org 10172 or heparin to rats. Thrombosis research, 1987, Dec-01, Volume: 48, Issue:5 Topics: Animals; Bleeding Time; Chondroitin Sulfates; Dermatan Sulfate; Factor Xa; Fibrinolytic Agents; Glycosaminoglycans; Heparin; Heparitin Sulfate; Male; Molecular Weight; Rats; Rats, Inbred Strains; Serine Endopeptidases; Thrombin; Thrombosis	1987
Thrombosis prophylaxis in an AT III deficient pregnant woman: application of a low molecular weight heparinoid. Thrombosis and haemostasis, 1986, Apr-30, Volume: 55, Issue:2 Topics: Adult; Antithrombin III Deficiency; Chondroitin Sulfates; Dermatan Sulfate; Female; Glycosaminoglycans; Heparin; Heparitin Sulfate; Humans; Pregnancy; Pregnancy Complications, Hematologic; Thrombosis	1986
Laboratory determination of heparin cofactor II. Archives of pathology & laboratory medicine, 1986, Volume: 110, Issue:12 Topics: Antithrombin III; Antithrombin III Deficiency; Antithrombins; Dermatan Sulfate; Disseminated Intravascular Coagulation; Female; Glycoproteins; Heparin Cofactor II; Humans; Liver Diseases; Methods; Pre-Eclampsia; Pregnancy; Thrombosis; Warfarin	1986
The haemorrhagic and antithrombotic effects of dermatan sulphate. British journal of haematology, 1986, Volume: 64, Issue:2 Topics: Animals; Blood Coagulation; Chondroitin; Dermatan Sulfate; Dose-Response Relationship, Drug; Factor X; Factor Xa; Hemorrhage; Heparin; Platelet Aggregation; Rabbits; Thrombosis	1986
In vivo activity of a new heparinoid. Pathology, 1985, Volume: 17, Issue:1 Topics: Animals; Chondroitin Sulfates; Dermatan Sulfate; Fibrinolytic Agents; Glycosaminoglycans; Heparin; Heparitin Sulfate; Rabbits; Thrombosis	1985